Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility (RESCU). An Analysis of Clinical Outcomes and Left Ventricular Recovery of STEMI Patients Treated With SSO2 Therapy After Primary Percutaneous Coronary Intervention (PPCI)

NCT05949515 is registered in ClinicalTrials.gov with Cardiovascular Research Foundation, New York as lead sponsor.

NCT NCT05949515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05949515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility (RESCU). An Analysis of Clinical Outcomes and Left Ventricular Recovery of STEMI Patients Treated With SSO2 Therapy After Primary Percutaneous Coronary Intervention (PPCI)
Lead sponsor
Cardiovascular Research Foundation, New York
Phase
Observational
Overall status
Completed
Start date
July 31, 2023
Completion date
March 31, 2024
Enrollment
403 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute st segment elevation myocardial infarction